Inventor · disambiguated record
Mandar V. Shah
Also filed as: SHAH MANDAR · SHAH MANDAR V
48 granted patents·27 pending applications·280 citations·filing 1993–2024
97Inventor score
Files withSOMERSET THERAPEUTICS LLC41SENTISS PHARMA PRIVATE LTD8ALCON INC6SHAH MANDAR V6ALCON MFG LTD2
Top patents by PatentIndex Score
75 records- 0196US11298315B2Triamcinolone and moxifloxacin compositionsSOMERSET THERAPEUTICS LLC·Filed 2021·Granted Apr 12, 2022·3 cites·33 claims
- 0294US11969410B2Low pH pilocarpine and brimonidine compound formulations and related methodsSOMERSET THERAPEUTICS LLC·Filed 2023·Granted Apr 30, 2024·1 cites·17 claims
- 0394US11857539B2Gel ophthalmic formulations of pilocarpine and brimonidine compounds and related methodsSOMERSET THERAPEUTICS LLC·Filed 2023·Granted Jan 2, 2024·1 cites·22 claims
- 0493US12156868B2Formulations of pilocarpine and brimonidine compounds and related methodsSOMERSET THERAPEUTICS LLC·Filed 2023·Granted Dec 3, 2024·1 cites·12 claims
- 0593US6486138B1Ophthalmic compositions containing galactomannan polymers and borateALCON MFG LTD·Filed 1999·Granted Nov 26, 2002·82 cites·22 claims
- 0692US6261547B1Gelling ophthalmic compositions containing xanthan gumALCON MFG LTD·Filed 1999·Granted Jul 17, 2001·145 cites·9 claims
- 0791US11285163B2Ophthalmic solutionSENTISS PHARMA PRIVATE LTD·Filed 2015·Granted Mar 29, 2022·7 cites·12 claims
- 0890US11696910B2Buffer-free, stable ophthalmological compositions of ketorolac and phenylephrine and applications thereofSOMERSET THERAPEUTICS LLC·Filed 2022·Granted Jul 11, 2023·1 cites·5 claims
- 0990US11478491B2Tobramycin compound-copolymer conjugates and derivative compositionsSOMERSET THERAPEUTICS LLC·Filed 2021·Granted Oct 25, 2022·1 cites·8 claims
- 1090US11478492B2Tobramycin compound conjugate formulationsSOMERSET THERAPEUTICS LLC·Filed 2021·Granted Oct 25, 2022·1 cites·12 claims
- 1189US11433115B2Glycopeptide antibiotics liquid formulations and methods and uses thereofSOMERSET THERAPEUTICS LLC·Filed 2021·Granted Sep 6, 2022·1 cites·24 claims
- 1289US11298368B2Efficient tobramycin compound conjugate compositionsSOMERSET THERAPEUTICS LLC·Filed 2021·Granted Apr 12, 2022·1 cites·9 claims
- 1388US11564931B2Low benzalkonium chloride bimatoprost ophthalmic compositions with effective penetration and preservation propertiesSOMERSET THERAPEUTICS LLC·Filed 2021·Granted Jan 31, 2023·1 cites·13 claims
- 1487US11400100B2Effective benzalkonium chloride-free bimatoprost ophthalmic compositionsSOMERSET THERAPEUTICS LLC·Filed 2020·Granted Aug 2, 2022·1 cites·29 claims
- 1582US11826429B2Pharmaceutical composition comprising brinzolamideSENTISS PHARMA PRIVATE LTD·Filed 2020·Granted Nov 28, 2023·1 cites·25 claims
- 1682US7578809B2Surface modified viscoelastics for ocular surgeryALCON INC·Filed 2005·Granted Aug 25, 2009·1 cites·10 claims
- 1780US11471403B2Limited particle size triamcinolone and moxifloxacin compositions and associated methods of useSOMERSET THERAPEUTICS LLC·Filed 2022·Granted Oct 18, 2022·0 cites·37 claims
- 1880US11446242B2Suspension component-specific triamcinolone and moxifloxacin compositions and associated methods of useSOMERSET THERAPEUTICS LLC·Filed 2022·Granted Sep 20, 2022·0 cites·33 claims
- 1980US11439591B2Moxifloxacin and triamcinolone compositions and associated methodsSOMERSET THERAPEUTICS LLC·Filed 2022·Granted Sep 13, 2022·0 cites·33 claims
- 2080US2022362274A1Combination products of tobramycin compounds and dexamethasone compoundsSOMERSET THERAPEUTICS LLC·Filed 2022·Application pending·0 cites
- 2178US11344566B2Tobramycin compound conjugates and derivative compositionsSOMERSET THERAPEUTICS LLC·Filed 2021·Granted May 31, 2022·0 cites·5 claims
- 2278US7084130B2Intraocular irrigating solution having improved flow characteristicsALCON INC·Filed 2001·Granted Aug 1, 2006·8 cites·17 claims
- 2377US12042502B2Enhanced penetration ophthalmic compositions of bimatoprost and timololSOMERSET THERAPEUTICS LLC·Filed 2023·Granted Jul 23, 2024·0 cites·19 claims
- 2477US11883382B2Buffer-free ophthalmological compositions of ketorolac and phenylephrine and applications thereofSOMERSET THERAPEUTICS LLC·Filed 2022·Granted Jan 30, 2024·0 cites·19 claims
- 2577US11395831B2Combination products of tobramycin compounds and dexameihasone compoundsSOMERSET THERAPEUTICS LLC·Filed 2021·Granted Jul 26, 2022·0 cites·10 claims
- 2676US11793789B2Treatment of ophthalmological conditions using buffer-free ophthalmological compositions of ketorolac and phenylephrineSOMERSET THERAPEUTICS LLC·Filed 2022·Granted Oct 24, 2023·0 cites·11 claims
- 2776US11590153B2Methods of treating eye disease with tobramycin-related compositionsSOMERSET THERAPEUTICS LLC·Filed 2021·Granted Feb 28, 2023·0 cites·22 claims
- 2876US11523987B2Trimcinolone and moxifloxacin methodsSOMERSET THERAPEUTICS LLC·Filed 2021·Granted Dec 13, 2022·0 cites·25 claims
- 2975US10517869B2Topical brimonidine tartrate ophthalmic solutionSENTISS PHARMA PRIVATE LTD·Filed 2014·Granted Dec 31, 2019·2 cites·2 claims
- 3075US7169755B2Solution for removing cataracts via liquefractureALCON INC·Filed 2001·Granted Jan 30, 2007·4 cites·13 claims
- 3174US12064440B2Ophthalmic gel compositions of bimatoprost and timolol and associated methodsSOMERSET THERAPEUTICS LLC·Filed 2023·Granted Aug 20, 2024·0 cites·17 claims
- 3274US2024398760A1Chelated, stable ophthalmological compositions of ketorolac and phenylephrine and applications thereofSOMERSET THERAPEUTICS LLC·Filed 2024·Application pending·0 cites
- 3373US10632198B2Pharmaceutical composition comprising brinzolamideSENTISS PHARMA PRIVATE LTD·Filed 2015·Granted Apr 28, 2020·1 cites·19 claims
- 3472US12029729B2Chelated, stable ophthalmological compositions of ketorolac and phenylephrine and applications thereofSOMERSET THERAPEUTICS LLC·Filed 2022·Granted Jul 9, 2024·0 cites·21 claims
- 3571US12343373B2Glycopeptide antibiotics liquid formulations and methods and uses thereofSOMERSET THERAPEUTICS LLC·Filed 2021·Granted Jul 1, 2025·0 cites·32 claims
- 3671US11786538B2Low benzalkonium chloride bimatoprost ophthalmic compositions with effective penetration and preservation propertiesSOMERSET THERAPEUTICS LLC·Filed 2020·Granted Oct 17, 2023·0 cites·20 claims
- 3771US11382910B2Loteprednol and moxifloxacin compositions and methodsSOMERSET THERAPEUTICS LLC·Filed 2021·Granted Jul 12, 2022·0 cites·31 claims
- 3870US12016855B2Prednisolone and moxifloxacin compositions and methodsSOMERSET THERAPEUTICS LLC·Filed 2021·Granted Jun 25, 2024·0 cites·35 claims
- 3970US11484538B2Bromfenac, prednisolone, and moxifloxacin compositions and methodsSOMERSET THERAPEUTICS LLC·Filed 2021·Granted Nov 1, 2022·0 cites·31 claims
- 4070US7363928B2Dilution resistant viscoelastic compositionsALCON INC·Filed 2004·Granted Apr 29, 2008·1 cites·3 claims
- 4167US11510930B2Gatifloxacin, prednisolone, and bromfenac compositions and methodsSOMERSET THERAPEUTICS LLC·Filed 2021·Granted Nov 29, 2022·0 cites·24 claims
- 4266US2022105100A1Safe brinzolamide and brimonidine compositions with enhanced benzalkonium chloride contentSOMERSET THERAPEUTICS LLC·Filed 2021·Application pending·0 cites
- 4366US2022105103A1Safe use of brinzolamide and brimonidine compositions with enhanced benzalkonium chloride contentSOMERSET THERAPEUTICS LLC·Filed 2021·Application pending·0 cites
- 4465US11857538B2Stable pilocarpine formulations with modified buffer characteristics and related methodsSOMERSET THERAPEUTICS LLC·Filed 2023·Granted Jan 2, 2024·0 cites·20 claims
- 4563US2020129505A1Topical Brimonidine Tartrate Ophthalmic SolutionSENTISS PHARMA PRIVATE LTD·Filed 2019·Application pending·0 cites
- 4662US2009258955A1Intraocular irrigating solution having improved flow characteristicsALCON INC·Filed 2009·Application pending·0 cites
- 4762US2007297990A1Self-preserving compositionSHAH MANDAR V·Filed 2006·Application pending·0 cites
- 4861US2022370396A1Methods for modulating conditions of the eye using novel latanoprost compound ophthalmic compositionsSOMERSET THERAPEUTICS LLC·Filed 2022·Application pending·0 cites
- 4961US2022354784A1Stable latanoprost compound ophthalmic compositionsSOMERSET THERAPEUTICS LLC·Filed 2022·Application pending·0 cites
- 5060US11400068B2Liquid ready-to-use formulation of levothyroxineSOMERSET THERAPEUTICS LLC·Filed 2021·Granted Aug 2, 2022·0 cites·20 claims
Showing the top 50 of 75 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →